Skip to main content

Table 2 Probability of success and failures at interim and final analysis at fixed and adaptive design scenarios

From: Design considerations and analysis planning of a phase 2a proof of concept study in rheumatoid arthritis in the presence of possible non-monotonicity

True Dose Response

Design Scenarios

Models Comparisons

Early success

Early failure

Final success

Final failure

Total Success

Mean subjects

Placebo like flat curve

Fixed Design (S1)

Bayesian Emax

ā€“

ā€“

0.06

0.94

0.06

64

Bayesian NDLM

ā€“

ā€“

0.17

0.83

0.17

64

No Adaptive design (S2)

Bayesian Emax

0.00

0.39

0.04

0.57

0.04

51

Bayesian NDLM

0.03

0.03

0.16

0.78

0.18

58

Half Adaptive design (S3)

Bayesian Emax

0.00

0.23

0.04

0.73

0.04

61

Bayesian NDLM

0.00

0.00

0.12

0.88

0.12

64

Adaptive (S4)

Bayesian Emax

0.03

0.39

0.04

0.54

0.07

55

Bayesian NDLM

0.01

0.01

0.12

0.86

0.13

64

Emax curve

Fixed Design (S1)

Bayesian Emax

ā€“

ā€“

0.98

0.02

0.98

64

Bayesian NDLM

ā€“

ā€“

0.98

0.02

0.98

64

No Adaptive design (S2)

Bayesian Emax

0.74

0.03

0.19

0.04

0.93

38

Bayesian NDLM

0.82

0.01

0.09

0.08

0.91

37

Half Adaptive design (S3)

Bayesian Emax

0.74

0.00

0.26

0.01

0.99

55

Bayesian NDLM

0.53

0.00

0.44

0.03

0.97

57

Adaptive (S4)

Bayesian Emax

0.80

0.03

0.15

0.02

0.95

42

Bayesian NDLM

0.55

0.00

0.41

0.04

0.96

56

Log Linear Curve

Fixed Design (S1)

Bayesian Emax

ā€“

ā€“

0.96

0.04

0.96

64

Bayesian NDLM

ā€“

ā€“

0.95

0.05

0.95

64

No Adaptive design (S2)

Bayesian Emax

0.64

0.05

0.24

0.08

0.88

40

Bayesian NDLM

0.74

0.00

0.15

0.11

0.89

40

Half Adaptive design (S3)

Bayesian Emax

0.58

0.00

0.40

0.02

0.98

57

Bayesian NDLM

0.45

0.00

0.47

0.08

0.92

58

Adaptive (S4)

Bayesian Emax

0.70

0.03

0.24

0.03

0.94

45

Bayesian NDLM

0.51

0.00

0.43

0.06

0.94

56

U-Shaped curve

Fixed Design (S1)

Bayesian Emax

ā€“

ā€“

0.26

0.74

0.26

64

Bayesian NDLM

ā€“

ā€“

0.92

0.08

0.92

64

No Adaptive design (S2)

Bayesian Emax

0.10

0.26

0.14

0.50

0.24

47

Bayesian NDLM

0.63

0.01

0.17

0.18

0.80

43

Half Adaptive design (S3)

Bayesian Emax

0.06

0.09

0.10

0.75

0.16

62

Bayesian NDLM

0.41

0.00

0.47

0.12

0.88

59

Adaptive (S4)

Bayesian Emax

0.14

0.24

0.10

0.52

0.24

54

Bayesian NDLM

0.42

0.00

0.44

0.14

0.86

58